Pharmacy News

Drug Delivery Systems

Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days

Articles(s): 1 - 5 of 5 Go To Page:

9/10/10 - Echo Therapeutics Announces Successful Completion of Clinical Trial for Prelude SkinPrep System and 4% Lidocaine Cream

Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude SkinPrep System for transdermal drug delivery, announced the completion of a clinical study of Prelude.

9/9/10 - Hospira and Smiths Medical to Co-Promote Infusion Pumps and Develop a Standardized Safety Monitoring and Reporting Solution across Infusion Systems

Hospira, Inc., a leading provider of clinical information and medication delivery technologies, and Smiths Medical, a leading global medical device manufacturer, today announced a commercial collaboration and co-development agreement for infusion pump systems.

9/8/10 - New drug delivery study findings have been reported by researchers at University of Athens, Department of Pharmaceutical Technology

Fresh data on drug delivery are presented in the report 'Utilization of hydrophilic swellable polymers as carriers for sustained drug delivery from matrices and three layer tablet systems.' "The materials used for the fabrication of these systems were hydrophilic swellable polymers namely Metolose, Polyox, Xanthan gum and an erodible material Gantr

9/8/10 - Research conducted at Johns Hopkins University has updated our knowledge about drug delivery

Current study results from the report, 'Topical dermatological drug delivery: quo vadis,' have been published. "Advancements in the life sciences coupled with a growing market for dermatologicals have facilitated the emergence of improved topical formulations and drug delivery systems.

9/7/10 - Vyteris to Present at Rodman & Renshaw Annual Global Investment Conference

09/07/10 Vyteris, Inc., manufacturer of the first FDA-approved active patch transdermal drug delivery system and a leader in active transdermal drug delivery technology, today announced that President and Chief Executive Officer Haro Hartounian, Ph.D. will present at the Rodman & Renshaw Annual Global Investment Conference on Monday, September 1

Articles(s): 1 - 5 of 5 Go To Page: